WO2001085908A9 - Proteine transmembranaire clasp-1 - Google Patents

Proteine transmembranaire clasp-1 Download PDF

Info

Publication number
WO2001085908A9
WO2001085908A9 PCT/US2001/011900 US0111900W WO0185908A9 WO 2001085908 A9 WO2001085908 A9 WO 2001085908A9 US 0111900 W US0111900 W US 0111900W WO 0185908 A9 WO0185908 A9 WO 0185908A9
Authority
WO
WIPO (PCT)
Prior art keywords
clasp
relates
transmembrane protein
polynucleotides
polypeptides
Prior art date
Application number
PCT/US2001/011900
Other languages
English (en)
Other versions
WO2001085908A3 (fr
WO2001085908A2 (fr
Inventor
Peter S. Lu
Mark M. Davis
Original Assignee
The Board Of Trustees Of The Leland Stanford Junior University
Arbor Vita Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/546,934 external-priority patent/US6565848B1/en
Application filed by The Board Of Trustees Of The Leland Stanford Junior University, Arbor Vita Corporation filed Critical The Board Of Trustees Of The Leland Stanford Junior University
Priority to AU2001251558A priority Critical patent/AU2001251558A1/en
Publication of WO2001085908A2 publication Critical patent/WO2001085908A2/fr
Publication of WO2001085908A3 publication Critical patent/WO2001085908A3/fr
Publication of WO2001085908A9 publication Critical patent/WO2001085908A9/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

L'invention concerne une molécule de surface, désignée comme protéine asymétrique de type cadherine 1 ('Clasp-1'). Plus spécifiquement, l'invention concerne des polynucléotides CLASP-1, des polypeptides CLASP-1, des protéines hybrides CLASP-1, et des anticorps CLASP-1. Cette invention concerne également des procédés permettant de moduler une réponse immunitaire par interférence avec une fonction de CLASP-1.
PCT/US2001/011900 2000-04-11 2001-04-11 Proteine transmembranaire clasp-1 WO2001085908A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2001251558A AU2001251558A1 (en) 2000-04-11 2001-04-11 Clasp-1 transmembrane protein

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US09/546,934 2000-04-11
US09/546,934 US6565848B1 (en) 1998-10-02 2000-04-11 Cadherin-like asymmetry protein-1, and methods for its use
US24054500P 2000-10-13 2000-10-13
US60/240,545 2000-10-13

Publications (3)

Publication Number Publication Date
WO2001085908A2 WO2001085908A2 (fr) 2001-11-15
WO2001085908A3 WO2001085908A3 (fr) 2009-06-18
WO2001085908A9 true WO2001085908A9 (fr) 2009-09-17

Family

ID=26933487

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/011900 WO2001085908A2 (fr) 2000-04-11 2001-04-11 Proteine transmembranaire clasp-1

Country Status (1)

Country Link
WO (1) WO2001085908A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2075256A2 (fr) 2002-01-14 2009-07-01 William Herman Ligands ciblés

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002526094A (ja) * 1998-10-02 2002-08-20 ザ ボード オブ トラスティーズ オブ ザ リーランド スタンフォード ジュニア ユニバーシティ カドヘリン様非対称蛋白質−１とそれを使用するための方法

Also Published As

Publication number Publication date
WO2001085908A3 (fr) 2009-06-18
WO2001085908A2 (fr) 2001-11-15

Similar Documents

Publication Publication Date Title
CA2155185A1 (fr) Reactifs par affinite, totalement synthetiques
WO2001094413A3 (fr) Acides nucleiques et polypeptides apparentes a b7 utiles pour effectuer une immunomodulation
EP1304382A3 (fr) Production de peptides dans des végétaux par fusions de protéines d'enveloppes virales
WO2004020404A3 (fr) Proteines hybrides de la transferrine-anticorps modifiees
AU4639396A (en) Cytokine designated lerk-7
EP1092774A3 (fr) Antigène de Borrelia burgdorferi OspA, gène le codant et leur utilisations
WO2004020405A3 (fr) Proteines de fusion de transferrine modifiees
WO2002002636A3 (fr) Proteine zupar i associee a une membrane
WO2003048334A3 (fr) Immunocytokines a selectivite modulee
WO2002099119A3 (fr) Acides nucleiques et polypeptides associes a b7 utiles pour l'immunomodulation
WO2002062999A8 (fr) Proteines et acides nucleiques codant pour celles-ci
WO2002046409A3 (fr) Proteines et acides nucleiques les codant
WO2002059315A3 (fr) Nouveaux acides nucleiques et polypeptides et procedes de leur utilisation
WO1995027059A1 (fr) L'afamine, une proteine albuminoide serique humaine
WO2000061747A3 (fr) Proteines transmembranaires clasp-2
WO2002031117A3 (fr) Proteines transmembranaires clasp-2
WO2002085922A3 (fr) Proteines et acides nucleiques codant pour celles-ci
WO2001085908A9 (fr) Proteine transmembranaire clasp-1
WO2004020588A3 (fr) Banques de proteines de fusion de la transferine
WO2001042295A3 (fr) Proteine transmembranaire clasp-7
WO2001042294A3 (fr) Proteine transmembranaire clasp-4
EP0885959A3 (fr) Protéine Wnt-5b humaine
WO2002090500A3 (fr) Nouvelles proteines humaines, polynucleotides codant ces proteines et methodes d'utilisation des proteines
WO2003025120A3 (fr) Proteines des membranes de type clasp
EP1892251A3 (fr) Acides nucléiques et polypeptides apparentés à B7 utiles pour effectuer une immunomodulation

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
NENP Non-entry into the national phase in:

Ref country code: DE

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase in:

Ref country code: JP